RT Journal Article
T1 Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study.
A1 Alvarez-Gutiérrez, Francisco Javier
A1 Gómez-Bastero Fernández, Ana
A1 Medina Gallardo, Juan Francisco
A1 Campo Sien, Carlos
A1 Rytilä, Paula
A1 Delgado Romero, Julio
K1 adherence
K1 asthma control
K1 clinical outcomes
K1 dry powder inhalers
K1 inhaler devices
K1 patient satisfaction
AB To study patient preference for and satisfaction with the Easyhaler® device and to assess ease of training and use of the inhaler in patients previously treated with a variety of dry powder inhalers (DPIs). We designed a non-interventional, cross-sectional, single-visit observational study of adult patients with persistent asthma referred to specialized care who had previously been treated with DPI inhalers for at least 3 months. Once clinical baseline data had been checked, patients filled in questionnaires on asthma control (GINA 2019), Feeling of Satisfaction with the Inhaler (FSI-10), and adherence (TAI and Morisky-Green questionnaires). Thereafter, all patients were trained in the use of Easyhaler. We assessed ease of use and satisfaction (FSI-10) with Easyhaler, as well as inhaler device preferences. We recruited 502 patients (mean age, 50.2 ± 16.2 y; 63.1% female), of whom 485 were evaluable. In response to the main objective of the study, we compared the values of the self-completed adapted FSI-10, to measure satisfaction with the inhaler. A significantly higher score in each item of the questionnaire was recorded for Easyhaler. Overall, 38% of patients showed exclusive preference for Easyhaler (compared with 15% for the previous device) or were evenly matched in 46% of cases. In the present study, Easyhaler achieved better patient ratings in terms of preference and satisfaction than previously used DPI devices. In order to improve asthma adherence strategies, patient preferences and device choice should be taken into account.
SN 1177-889X
YR 2021
FD 2021-02-16
LK http://hdl.handle.net/10668/17230
UL http://hdl.handle.net/10668/17230
LA en
DS RISalud
RD Apr 6, 2025